Medical Device News Magazine

First Successful Total Knee Replacement Performed in the U.S. Using Pixee Medical’s Knee+ Augmented-Reality Platform

Pixee Medical’s Knee+ AR computer-assisted orthopedic solution deployed for the first-ever use in the United States with the MicroPort Evolution® Medial-Pivot Knee system

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

MicroPort Orthopedics, a global leader in orthopedic devices and technologies, today announces the successful completion of the first surgery in the U.S. utilizing Pixee Medical, an FDA-cleared augmented reality surgical application for assistance in total knee arthroplasties.

The surgery was performed by Dr. Antonia F. Chen, M.D., M.B.A., an orthopedic surgeon at Brigham and Women’s Hospital in Boston, MA, using MicroPort Orthopedics Evolution® Medial-Pivot Knee system, designed to deliver a high degree of stability and motion, leading to increased patient satisfaction and survivorship. In conjunction with Pixee’s Knee+ platform, the surgeon is able to achieve excellent precision and control, which may result in more efficiency in the operating room and a quicker return to full function for the patient.
Pixee Medical’s Knee+ is a patented platform designed to assist orthopedic surgeons to perform surgeries better and faster by providing real-time positioning of instruments, right in their field of view via smartglasses. Knee+ is intuitive and requires minimal training since it does not change the overall technique for 90 percent of surgeons who use a conventional technique but have never utilized navigation or robots.
“Our mission at MicroPort is to help the patient achieve full function, faster – and this ability to enhance precision and results during surgery will do just that,” said Benny Hagag, President of MicroPort Orthopedics. “The Pixee platform will be transformative in the continued efficiency and precision of our device systems.”
“The first use of Knee+ in Boston is an important step forward as the U.S. represents 50 percent of the worldwide market,” said Sébastien Henry, Founder and CEO of Pixee Medical. “Pixee’s platform is designed to become the cornerstone of data acquisition and exchange during surgery. We look forward to expanding the use of this technology within the US market.”
MicroPort Orthopedics offers various products and techniques to help patients receiving total hip and knee replacements achieve Full Function, Faster. For more information on MicroPort Orthopedics, visit www.microportortho.com.
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”